Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations
Matthias Scheffler(University Hospital Cologne), Alessandra Holzem(University Hospital Cologne), Anna Kron(University Hospital Cologne), Lucia Nogová(University Hospital Cologne), Michaela A. Ihle(University of Cologne), Cornelia von Levetzow(University Hospital Cologne), Jana Fassunke(University of Cologne), C. Wömpner(University Hospital Cologne), Elisabeth Bitter(University Hospital Cologne), Sophia Koleczko(University Hospital Cologne), Diana S.Y. Abdulla(University Hospital Cologne), Sebastian Michels(University Hospital Cologne), Rieke Fischer(University Hospital Cologne), Richard Riedel(University Hospital Cologne), Jan-Philipp Weber(University Hospital Cologne), Theresa Westphal(University Hospital Cologne), Ulrich Gerigk(St. Marien-Hospital Bonn), Jens Kern(Klinikum Würzburg Mitte), Britta Kaminsky(Krankenhaus Bethanien), Winfried Randerath(Krankenhaus Bethanien), K Kambartel(Krankenhaus Bethanien), Sabine Merkelbach‐Bruse(University of Cologne), Reinhard Büttner(University of Cologne), Jürgen Wolf(University Hospital Cologne)
Cited by 24